Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: PDavid who wrote (2766)	12/7/1998 10:25:00 AM
From: shero	Read Replies (2) \| Respond to of 3702

PDavid: That's not quite right. They were sent home after one treatment because that's what the phase 1 protocol called for. I don't think its a great leap of logic to go from the point if TCLN has the money for phase 2 then they have the money to treat the phase 1' patients w/more than one dose. Blame it on the FDA. ALYS: Some one on Yahoo posted the terms of the "alledged" deal to license LYM-1. If that person is right I hope the SEC and TCLN go after that person with all the weight they can bring to bear. As I've said before It's one thing to get inside info. It's criminal to post it. It makes us look bad. It could ruin the deal.